Herantis Pharma PLC.
Records under this name other than the patents Herantis Pharma PLC. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 5 of 5 · Back to Herantis Pharma PLC.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,853,166 | Neurotrophic Factor Manf and Uses Thereof Lapsed on the fee record Ended Oct 7, 2026 · High confidence | Lapsed on the fee record | Ended Oct 7, 2026 | High confidence |
| US 9,592,270 | Neurotrophic Factor Manf and Uses Thereof Lapsed on the fee record Ended Mar 14, 2025 · High confidence | Lapsed on the fee record | Ended Mar 14, 2025 | High confidence |
| US 7,452,969 | Neurotrophic factor protein and uses thereof Term ended Term ended Feb 14, 2024 · From the USPTO record | Term ended | Term ended Feb 14, 2024 | From the USPTO record |
| US 8,980,821 | Treatment with a Pharmaceutical Composition Comprising MANF2 Nucleic Acid Term ended Term ended Aug 27, 2023 · Medium confidence | Term ended | Term ended Aug 27, 2023 | Medium confidence |
| US 8,133,906 | Method of treating amblyopia Lapsed on the fee record Ended Mar 13, 2016 · From the USPTO record | Lapsed on the fee record | Ended Mar 13, 2016 | From the USPTO record |